Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Anika Therapeutics Inc. logo

Anika Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 385 M  90-day average vol: 57,106

Previous close: 25.93  Open: 25.84  Bid: 10.43  Ask: 28.0
52 week range    
Last updated: Friday 21st June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


ANIK Cash Flow

(Increase) Decrease in inventories-3 M-2 M-3 M-2 M-7 M-8 M-6 M-14 M-7 M-7 M
(Increase) Decrease in other current assets101986.0
(Increase) Decrease in other current liabilities-3 M-2 M-109000.016000.0-708000.0
(Increase) Decrease in payables775292.08 M11 M-9 M4 M-749000.0-318000.0-1 M-2 M3 M
(Increase) Decrease in receivables2 M898000.0-5 M-6 M3 M3 M-2 M6 M-6216.0-6 M
Acquisitions-95 M-476000.0
Amortization of intangibles1 M18 M14 M8 M
AssetImpairmentCharge171089.0378000.0907000.0654000.0695000.04 M2 M50 M7 M5 M
CapitalExpenditureReported440890.02 M9 M14 M9 M5 M3 M2 M5 M7 M
Cash at beginning of period44 M63 M100 M111 M104 M133 M89 M157 M96 M94 M
Cash at end of period63 M100 M111 M104 M133 M89 M247 M96 M96 M86 M
Cash flow25 M40 M39 M24 M41 M35 M37 M42 M36 M4 M
CashFlowFromContinuingInvestingActivities-253155.0-8 M-30 M-7 M-12 M-50 M40 M-100 M-24 M-7 M
ChangeInAccountPayable622928.0-750000.06 M-5 M4 M-2 M767000.0822000.0-1 M2 M
ChangeInAccruedExpense-376897.0-1 M-199000.02 M-1 M1 M4 M-142000.04 M-443000.0
ChangeInIncomeTaxPayable152364.08 M5 M-4 M367000.0922000.0-1 M-2 M-1 M1 M
ChangeInInterestPayable-376897.0-1 M-199000.02 M-1 M1 M4 M-142000.0
ChangeInPayablesAndAccruedExpense398395.06 M11 M-7 M3 M564000.03 M-1 M1 M3 M
ChangeInPrepaidAssets306505.0585000.089000.0-898000.0-1 M899000.0-2 M-2 M1 M-792000.0
ChangeInTaxPayable152364.08 M5 M-4 M367000.0922000.0-1 M-2 M-1 M1 M
ChangeInWorkingCapital-3 M4 M3 M-16 M-2 M-3 M-6 M-11 M-4 M-10 M
ChangesInAccountReceivables2 M898000.0-5 M-6 M3 M3 M-2 M6 M-6216.0-6 M
CommonStockPayments-25 M-30 M-30 M
Current deferred income taxes2 M815000.0-747000.0-65000.0-1 M-2 M794000.0-4 M-2 M-5 M
Deferred income taxes2 M815000.0-747000.0-65000.0-1 M-2 M794000.0-4 M-2 M-5 M
Depreciation5 M5 M4 M4 M4 M6 M6 M6 M6 M7 M
Depreciation unreconciled5 M5 M4 M4 M4 M6 M7 M26 M22 M16 M
DepreciationAndAmortization5 M5 M4 M4 M4 M6 M7 M26 M22 M16 M
Effect of exchange rate changes43066.0-184000.0-208000.0-138000.0349000.029000.0-133000.0327000.069000.0-130000.0
ExcessTaxBenefitFromStockBasedCompensation-856830.0-10 M-847000.0-647000.0
FinancingCashFlow-6 M5 M2 M-24 M314000.0-29 M81 M-4 M-7 M-5 M
Free cash flow25 M38 M30 M10 M32 M30 M34 M40 M3 M-3 M
IncomeTaxPaidSupplementalData10 M14 M13 M23 M15 M6 M9 M993000.01 M106000.0
Issuance of capital stock665000.0
IssuanceOfDebt-10 M-558000.0-201000.0-284000.0
Net cash from financing activities-6 M5 M2 M-24 M314000.0-29 M81 M-4 M-7 M-5 M
Net cash from investing activities-253155.0-8 M-30 M-7 M-12 M-50 M40 M-100 M-3 M-7 M
Net cash from operating activities25 M40 M39 M24 M41 M35 M37 M42 M8 M4 M
Net change in cash & cash equivalents19 M37 M11 M-6 M29 M-44 M157 M-62 M-1 M-8 M
Net income from continuing operations21 M38 M31 M33 M32 M19 M27 M-24 M4 M-15 M
NetBusinessPurchaseAndSale-123 M-22 M
NetCommonStockIssuance-25 M-30 M-30 M665000.0
NetInvestmentPropertiesPurchaseAndSale-7 M-21 M7 M-3 M-46 M43 M25 M3 M
NetInvestmentPurchaseAndSale-7 M-21 M7 M-3 M-46 M43 M25 M3 M
NetIssuancePaymentsOfDebt-10 M-558000.0-201000.0-284000.0
NetLongTermDebtIssuance-10 M-558000.0-201000.0-284000.0
NetPPEPurchaseAndSale-253155.0-2 M-9 M-14 M-9 M-5 M-3 M-2 M-5 M-7 M
Operating (gains) losses-126284.0150000.0-219000.0902000.0265000.0993000.0
Other financing charges net856830.03 M847000.0647000.0-2 M89 M-5 M-8 M-5 M
Other investing changes net-29 M
Other non-cash items659841.0-8 M2 M4 M8 M16 M7 M54 M14 M19 M
ProceedsFromStockOptionExercised3 M2 M1 M1 M314000.03 M22 M2 M1 M16000.0
Purchase of Float term investments-104 M-20 M
Purchase of property plant & equipment-253155.0-2 M-9 M-14 M-9 M-5 M-3 M-2 M-5 M-7 M
Purchase of short term investments50 M
PurchaseOfInvestment-27 M-45 M-39 M-45 M-92 M-104 M-20 M
PurchaseOfLongTermInvestments-27 M-45 M-39 M-45 M-92 M-104 M-20 M
PurchaseOfPPE-440890.0-2 M-9 M-14 M-9 M-5 M-3 M-2 M-5 M-7 M
Repayment of debt-10 M-51 M-201000.0-284000.0
RepaymentOfDebt-10 M-51 M-201000.0-284000.0
Repurchase of capital stock-25 M-30 M-30 M
Revenue per share1 M20 M16 M10 M
Sale of short term investments20 M24 M47 M42 M46 M146 M45 M3 M
SaleOfBusiness-29 M-21 M
SaleOfInvestment20 M24 M47 M42 M46 M146 M45 M3 M
StockBasedCompensation1 M2 M2 M3 M6 M11 M6 M5 M11 M14 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University